IASLC molecular subcommittee lung cancer dataset develops international biomarker snapshot
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
10 September 2021Active surveillance for low-risk prostate cancer: New data on risk factors for switching to active treatment
10 September 2021IASLC molecular subcommittee lung cancer dataset develops international biomarker snapshot
For the first time, the IASLC’s Staging and Prognostic Factors Committee (SPFC) has accumulated molecular biomarker data to complement Tumor, Node, and Metastasis (TNM)-based prognostication. Results from the committee’s first effort were reported today at the IASLC 2021 World Conference on Lung Cancer in OA06: Prognosis and Staging.
